| abstract |
The invention discloses an application of multiple serum tumor markers in combined pancreatic cancer specific early diagnosis and curative effect monitoring detection, particularly relates to the technical field of medical detection, and particularly relates to an in-vitro detection kit and a detection method for multiple serological indexes in combined detection to assist pancreatic cancer early specific diagnosis, curative effect monitoring and prognosis evaluation in clinical medical detection. The indexes of the invention comprise a plurality of multi-index combinations in MMP II, MIC-1, REG4, LAMC2, OPN, GPC-1, CA19-9 and CEA. The optimal index and multi-index combined detection effectively overcomes the defects of low sensitivity and low specificity of single index or combined detection in the current pancreatic cancer clinical medical detection. The method provides a new method for early diagnosis and curative effect monitoring and detection of pancreatic cancer, and improves diagnosis and treatment efficiency and improves prognosis evaluation for early diagnosis and early treatment of pancreatic cancer. |